Literature DB >> 10232455

Changes of periodontal status in patients with Down syndrome during a 7-year period.

M B Agholme1, G Dahllöf, T Modéer.   

Abstract

The development of periodontal disease in Down syndrome adolescents (n = 34) was studied clinically and on intraoral radiographs during a 7-yr period. The occurrence of gingival inflammation (GBI), pathological periodontal pockets (>4 mm), sub- and supragingival calculus, alveolar bone height, alveolar bone loss, and the occurrence of the periodontal pathogens Actinobacillus actinomycetemcomitans, Capnocytophaga, and Porphyromonas gingivalis in subgingival plaque were determined. Of the subjects, 41% had one or more pathological periodontal pockets at baseline compared to 65% at follow-up. At the baseline examination, 35% of the individuals exhibited alveolar bone loss compared to 74% at the follow-up. The median value of sites with alveolar bone loss increased from 0 to 1, the new lesions mainly being located in the incisor region. The estimated annual reduction of alveolar bone height in each subject was 0.04 mm on average. The occurrence of the periodontal pathogens A. actinomycetemcomitans, Capnocytophaga, and P. gingivalis in subgingival plaque did not differ between baseline and follow-up. The results of the present study indicate that the frequency of periodontitis, mainly located on the lower incisors, markedly increased during a 7-yr period in Down syndrome individuals, although the severity and progression was limited compared to what has previously been described.

Entities:  

Mesh:

Year:  1999        PMID: 10232455     DOI: 10.1046/j.0909-8836.1999.eos107202.x

Source DB:  PubMed          Journal:  Eur J Oral Sci        ISSN: 0909-8836            Impact factor:   2.612


  5 in total

1.  Subgingival microbiota in adult Down syndrome periodontitis.

Authors:  A Khocht; T Yaskell; M Janal; B F Turner; T E Rams; A D Haffajee; S S Socransky
Journal:  J Periodontal Res       Date:  2012-01-03       Impact factor: 4.419

Review 2.  Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment.

Authors:  W J Loesche; N S Grossman
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  Assessment of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans in Down's syndrome subjects and systemically healthy subjects: A comparative clinical trial.

Authors:  Nizar Ahmed; Harinath Parthasarathy; Mohamed Arshad; Dhayanand John Victor; Danny Mathew; Siva Sankari
Journal:  J Indian Soc Periodontol       Date:  2014 Nov-Dec

Review 4.  Prevention and Periodontal Treatment in Down Syndrome Patients: A Systematic Review.

Authors:  Rafael Ferreira; Raphaella Coelho Michel; Sebastião Luiz Aguiar Greghi; Maria Lúcia Rubo de Resende; Adriana Campos Passanezi Sant'Ana; Carla Andreotti Damante; Mariana Schutzer Ragghianti Zangrando
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

5.  Oral microbiome in down syndrome and its implications on oral health.

Authors:  Jesse R Willis; Susana Iraola-Guzmán; Ester Saus; Ewa Ksiezopolska; Luca Cozzuto; Luis A Bejarano; Nuria Andreu-Somavilla; Miriam Alloza-Trabado; Anna Puig-Sola; Andrea Blanco; Elisabetta Broglio; Carlo Carolis; Jochen Hecht; Julia Ponomarenko; Toni Gabaldón
Journal:  J Oral Microbiol       Date:  2020-12-30       Impact factor: 5.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.